NHS cancer jab could mean patients spend hours less in hospital

• Injectable immunotherapy formulation reduces administration time from hours to minutes, potentially decreasing hospital visits and improving patient experience
• Thousands of NHS cancer patients will be offered this new treatment option, expanding access to immunotherapy across the service
• Shorter infusion times may help reduce healthcare resource burden and allow patients to return to normal activities more quickly

Thousands of patients will be offered a new injectable form of an immunotherapy drug that takes minutes.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.